| Grant number: | 14/26200-9 |
| Support Opportunities: | Regular Research Grants |
| Start date: | August 01, 2015 |
| End date: | July 31, 2017 |
| Field of knowledge: | Health Sciences - Pharmacy - Pharmaceutical Technology |
| Principal Investigator: | Daniele Ribeiro de Araujo |
| Grantee: | Daniele Ribeiro de Araujo |
| Host Institution: | Centro de Ciências Naturais e Humanas (CCNH). Universidade Federal do ABC (UFABC). Santo André , SP, Brazil |
| City of the host institution: | Santo André |
| Associated researchers: | Christiane Bertachini Lombello |
Abstract
The development of new carrier systems and modified release formulations have allowed the possible modulation of physical-chemical, pharmacodynamic and pharmacokinetic properties, enhancing the therapeutic effects and promoting the clinical use of different molecules. Among the various carrier systems, the self-assembled micelles, such as those formed by copolymers known as poloxamers. The poloxamers have been investigated as drug delivery systems due to their ability to form gels at temperatures close to the body (sol-gel transition), making them effective bases for inclusion complexes and nanoparticles, favoring the administration of formulations by different routes and controlling the release rate of drugs for long periods of time. The use of poloxamers with different physico-chemical characteristics (such as the poloxamers 407 and 403) is interesting to investigate properties of the hybrid systems as drugs carriers and also their influence on the sol-gel transition, micellar structure, rheological properties and the release rate of the incorporated drug. As an immediate application, the main idea of this purpose is to provide potential novel therapeutic strategies and pharmaceutical formulations for the treatment of chronic inflammatory diseases such as rheumatoid arthritis and ulcerative colitis. Thus, this proposal involves the preparation and physicochemical characterization, the in vitro cytotoxicity studies and the in vivo therapeutic efficacy after administration by intra-articular or intra-colonic routes (for naproxen and budesonide, respectively). For this reason, the drugs will be encapsulated in nanoparticles (naproxen) or complexed with cyclodextrins (budesonide) and, subsequently, dispersed in thermoreversible hydrogels, for the development of nanostructured hybrid systems. (AU)
| Articles published in Agência FAPESP Newsletter about the research grant: |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
PROCESSO DE PRODUÇÃO DE NANOPARTÍCULAS DE QUITOSANA-TRIPOLIFOSFATO DISPERSAS EM HIDROGÉIS TERMORREVERSÍVEIS PARA LIBERAÇÃO INTRA-ARTICULAR DE FÁRMACOS, PRODUTO OBTIDO E APLICAÇÃO BR 10 2016 018180 1 - Fundação Universidade Federal do ABC (UFABC) ; Universidade Estadual de Campinas Unicamp ; Universidade Estadual Paulista Júlio de Mesquita Filho (Unesp) . Daniele Ribeiro De Araújo; Kelli Cristina Freitas Mariano; Leonardo Fernandes Fraceto; ; Estefânia Vangelie Ramos Campos; Jhones Luiz De Oliveira; Eneida De Paula - January 2016, 01
PROCESSO DE OBTENÇÃO DE BIOMATERIAL COMPÓSITO PARA TRATAMENTO, RECONSTRUÇÃO E SUBSTITUIÇÃO ÓSSEA E PRODUTO OBTIDO BR 10 2017 006427 1 - Fundação Universidade Federal do ABC (UFABC) . Juliana Marchi; Daniele Ribeiro De Araújo; Karen Cristina Kai; Tomaz Puga Leivas - January 2017, 01